Involvement of collagenolytic enzymes in degradation of extracellular matrices during tumor invasion has been documented by several investigators. Past studies have shown that fibroblasts are stimulated to produce type I collagen-degrading enzyme by a tumor cell factor (TCSF) present on the tumor cell membrane. Subsequently, using a human tumor cell line LX-1, monoclonal antibodies were raised against TCSF and the factor was purified. TCSF has a mol wt. of 58 kD, and is present on the outer surface of tumor cells but not fibroblasts. It stimulates collagenase and collagenase mRNA production in fibroblasts. Several low mol wt. proteins are present in conditioned medium from tumor cells which are immunologically cross-reactive with TCSF, suggesting their generation by proteolytic cleavage of the membrane TCSF. Based on these findings we plan: 1) To obtain internal peptide sequences for TCSF to be used for conformation of the identity of cDNA clones and for design of oligonucleotide probes. 2) To characterize the cDNA clone(s) for TCSF that we have already obtained and others that will be obtained in the future for use in the study of its homology with other agents, particularly collagenase stimulatory agents, and its expression in normal and tumor cells and tissues. 3) To screen a variety of normal and tumor tissues to establish its distribution and possible correlations with degrees of tumor invasion. In addition, we will begin to examine other potential properties of TCSF. These experiments will yield further information regarding the molecular nature and properties of TCSF, and the regulation of its production in normal vs. neoplastic tissue. In turn this knowledge may lead to the development of therapeutic methods involving prevention of its action.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA038817-06
Application #
3177162
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1985-07-01
Project End
1994-03-31
Budget Start
1992-04-02
Budget End
1994-03-31
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Tufts University
Department
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02111
Guo, H; Majmudar, G; Jensen, T C et al. (1998) Characterization of the gene for human EMMPRIN, a tumor cell surface inducer of matrix metalloproteinases. Gene 220:99-108
Guo, H; Zucker, S; Gordon, M K et al. (1997) Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem 272:24-7
DeCastro, R; Zhang, Y; Guo, H et al. (1996) Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer. J Invest Dermatol 106:1260-5
Biswas, C; Zhang, Y; DeCastro, R et al. (1995) The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 55:434-9
Muraoka, K; Nabeshima, K; Murayama, T et al. (1993) Enhanced expression of a tumor-cell-derived collagenase-stimulatory factor in urothelial carcinoma: its usefulness as a tumor marker for bladder cancers. Int J Cancer 55:19-26
Kataoka, H; DeCastro, R; Zucker, S et al. (1993) Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res 53:3154-8
Nabeshima, K; Lane, W S; Biswas, C (1991) Partial sequencing and characterization of the tumor cell-derived collagenase stimulatory factor. Arch Biochem Biophys 285:90-6
Kataoka, H; Biswas, C (1991) Nucleotide sequence of a cDNA for the alpha subunit of human mitochondrial ATP synthase. Biochim Biophys Acta 1089:393-5
Ellis, S M; Nabeshima, K; Biswas, C (1989) Monoclonal antibody preparation and purification of a tumor cell collagenase-stimulatory factor. Cancer Res 49:3385-91
Prescott, J; Troccoli, N; Biswas, C (1989) Coordinate increase in collagenase mRNA and enzyme levels in human fibroblasts treated with the tumor cell factor, TCSF. Biochem Int 19:257-66

Showing the most recent 10 out of 11 publications